Ghiath M. Sukhtian's most recent trade in Outlook Therapeutics Inc was a trade of 8,571,428 Warrants (right to buy) done . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 8,571,428 | 8,571,428 | - | - | Warrants (right to buy) | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.40 per share. | 27 May 2025 | 4,285,714 | 13,552,359 (25%) | 8% | 1.4 | 6,000,000 | Common Stock |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.51 per share. | 17 Jan 2025 | 3,458,571 | 9,266,645 (17%) | 6% | 2.5 | 8,681,013 | Common Stock |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 3,458,571 | 3,458,571 | - | - | Warrants (right to buy) | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 2,305,714 | 5,808,074 (10%) | 4% | - | Common Stock | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 3,458,571 | 3,458,571 | - | - | Warrants (right to buy) | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 3,458,571 | 3,458,571 | - | - | Warrants (right to buy) | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jan 2024 | 3,458,571 | 0 | - | - | Warrants (right to buy) | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 3,458,571 | 3,458,571 | - | - | Warrants (right to buy) | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2024 | 3,458,571 | 0 | - | - | Warrants (right to buy) | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 28 Dec 2022 | 14,230,418 | 70,047,204 (131%) | 26% | 0.9 | 12,499,999 | Common Stock |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 21 Apr 2022 | 27,982,529 | 55,816,786 (105%) | 52% | - | Common Stock | |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Other type of transaction at price $ 1.25 per share. | 01 Feb 2022 | 2,500,000 | 27,982,529 (52%) | 4% | 1.3 | 3,125,000 | Common Stock |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 29 Nov 2021 | 16,000,000 | 27,834,257 (52%) | 30% | 1.3 | 20,000,000 | Common Stock |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.00 per share. | 10 Feb 2021 | 1,013,627 | 11,834,257 (22%) | 1% | 1 | 1,013,627 | Common Stock |
| Outlook Therapeutics Inc | Ghiath M. Sukhtian | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 02 Feb 2021 | 8,360,000 | 10,820,630 (20%) | 15% | 1 | 8,360,000 | Common Stock |